APA (7th ed.) Citation

A, L., B, S., M, W., N, R., D, S., I, K., . . . H, M. (2026). Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: A multi-institution study. Breast cancer research and treatment, 217(2), . https://doi.org/10.1007/s10549-026-07984-8

Chicago Style (17th ed.) Citation

A, LeVee, Santos B, Wong M, Ruel N, Schmolze D, Kang I, Tsai K, Mortimer J, and McArthur H. "Predictors of Pathologic Complete Response in Early-stage Triple-negative Breast Cancer Treated with Neoadjuvant Chemo-immunotherapy: A Multi-institution Study." Breast Cancer Research and Treatment 217, no. 2 (2026). https://doi.org/10.1007/s10549-026-07984-8.

MLA (9th ed.) Citation

A, LeVee, et al. "Predictors of Pathologic Complete Response in Early-stage Triple-negative Breast Cancer Treated with Neoadjuvant Chemo-immunotherapy: A Multi-institution Study." Breast Cancer Research and Treatment, vol. 217, no. 2, 2026, https://doi.org/10.1007/s10549-026-07984-8.